A Multidisciplinary Self-Directed Learning Module Improves Knowledge of a Quality Improvement Instrument: The HEART Pathway.. Hartman ND, Harper EN, Leppert LM, Browning BM, Askew K, Manthey DE, Mahler SA. J Healthc Qual. ; 40(1):e9-e14.
Welcome to the Real World: Do the Conditions of FDA Approval Devalue High-sensitivity Troponin?. Body R, Mahler S. Acad Emerg Med. 2017 Oct; 24(10):1278-1280.
Validation of the No Objective Testing Rule and Comparison to the HEART Pathway.. Stopyra JP, Miller CD, Hiestand BC, Lefebvre CW, Nicks BA, Cline DM, Askew KL, Riley RF, Russell GB, Hoekstra JW, Mahler SA. Acad Emerg Med. 2017 Sep; 24(9):1165-1168.
In Reply.. Stopyra JP, Miller CD, Mahler SA. Acad Emerg Med. 2017 Sep; 24(9):1171-1172.
Use of the HEART Pathway with high sensitivity cardiac troponins: A secondary analysis.. Mahler SA, Stopyra JP, Apple FS, Riley RF, Russell GB, Hiestand BC, Hoekstra JW, Lefebvre CW, Nicks BA, Cline DM, Askew KL, Herrington DM, Burke GL, Miller CD. Clin. Biochem. 2017 May; 50(7-8):401-407.
